HDFC Bank Ltd, India's largest private sector lender, has experienced a significant downturn in its share price throughout 2026, with the stock falling nearly 30% year-to-date. On Thursday, October 22, 2026, shares declined another 2.4%, pushing its market capitalization below Rs 10.70 lakh crore and bringing it close to its 52-week low recorded in September.
Foreign Investors Reduce Holdings
A notable factor contributing to the stock's weakness is the substantial reduction in exposure by foreign institutional investors (FIIs). Their shareholding in HDFC Bank decreased by 9 percentage points, falling from 48.4% a year ago to 39.4% by September 30, 2026. Conversely, domestic mutual funds increased their stake during the same period, rising from 26% to 31.9%.
Underlying Pressures and Challenges
Market experts point to several key issues driving the selling pressure. Continued margin pressure, particularly evident in the bank's Q2 FY27 results, has dampened earnings growth expectations. Net interest margin (NIM) contracted to 3.16%, even as consolidated net profit rose 5.6% year-on-year to Rs 20,700 crore for the September 2026 quarter, with net interest income (NII) growing 9.7% to Rs 34,619 crore.
Structural challenges stemming from the 2023 merger with HDFC Ltd continue to weigh on sentiment. Additionally, leadership and governance concerns have surfaced, including a Bloomberg report detailing an internal probe into two senior executives for allegedly disclosing confidential business strategies and market-sensitive information. The bank has not publicly commented on this report. Recently, Anup Bagchi was appointed as the new CEO.
Brokerage Outlook Remains Largely Positive
Despite the sharp decline in share price, brokerage sentiment largely remains optimistic. Out of 50 brokerage firms, 48 currently maintain a 'Buy' rating on HDFC Bank, with only two assigning a 'Hold' rating and none recommending a 'Sell'.
Brokerage firms have set ambitious target prices, suggesting significant upside potential. BNP Paribas leads with a target price of Rs 1,270, implying an upside of approximately 85% from recent lows. InCred Research has an 'Add' rating with a target of Rs 1,178, while Bernstein rates it 'Outperform' with a Rs 1,150 target. YES Securities, Kotak Institutional Equities, Emkay Global, and CLSA all have 'Buy' or 'Accumulate' ratings with targets ranging from Rs 1,050 to Rs 1,075.